Answers are grounded in this paper and cite their sources.
The June Hot Topics focuses on the challenges venetoclax regimens have faced in multiple myeloma trials.
No takes yet. Share an insight, caveat, or question.
Avigan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: